Zhi-Gang Zhang

Zhi-Gang Zhang


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2012 in The Lancet Oncology
Verified
Journal Article
Closed access
QSQiujin Shen
Qiujin Shen
JFJia Fan
Jia Fan
XYXin-Rong Yang
Xin-Rong Yang
YTYexiong Tan
Yexiong Tan
WZWeifeng Zhao
Weifeng Zhao
WQWenxin Qin
Wenxin Qin

4 October 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
WQWeiting Qin
Weiting Qin
LHlp hu
lp hu
Xueli ZhangXueli Zhang
Xueli Zhang
SJShuheng Jiang
Shuheng Jiang
JLJun Li
Jun Li
XWXu Wang
Xu Wang
The recent success of PD-1 and PD-L1 blockade in cancer therapy illustrates the important role of the PD-1/PD-L1 pathway in the regulation of antitumor immune responses. However, signaling regulated by the PD-1/PD-L pathway is also associated with substantial inflammatory effects that can resemble those in autoimmune responses, chronic infection, and sepsis, consistent with the role of this pathway in balancing protective immunity and immunopathology, as well as in homeostasis and tolerance. Targeting PD-1/PD-L1 to treat cancer has shown benefits in many patients, suggesting a promising opportunity to target this pathway in autoimmune and inflammatory disorders. Here, we systematically evaluate the diverse biological functions of the PD-1/PD-L pathway in immune-mediated diseases and the relevant mechanisms that control these immune reactions.

1 July 2017 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
SJShu-Heng Jiang
Shu-Heng Jiang
JLJun Li
Jun Li
FDFang-Yuan Dong
Fang-Yuan Dong
ZCZhong Chen
Zhong Chen
DLDe-Jun Liu
De-Jun Liu
ZZZhi-Gang Zhang
Zhi-Gang Zhang

16 September 2019 in Oncogene
Verified
Journal Article
Closed access
PDF file
SJShu-Heng Jiang
Shu-Heng Jiang
LHlp hu
lp hu
XWXu Wang
Xu Wang
JLJun Li
Jun Li
ZZZhi-Gang Zhang
Zhi-Gang Zhang

6 February 2020 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
JLJin-Tao Li
Jin-Tao Li
MYMiao Yin
Miao Yin
DWDi Wang
Di Wang
JWJian Wang
Jian Wang
MLMing-Zhu Lei
Ming-Zhu Lei
QLQun-Ying Lei
Qun-Ying Lei

15 May 2020 in Cancer Research
Verified
Journal Article
Closed access
PDF file
MYMin-Wei Yang
Min-Wei Yang
LTLing-Ye Tao
Ling-Ye Tao
YJYong-Sheng Jiang
Yong-Sheng Jiang
JYJian-Yu Yang
Jian-Yu Yang
YHYan-Miao Huo
Yan-Miao Huo
YSYongwei Sun
Yongwei Sun
Perineural invasion is a common feature of pancreatic ductal adenocarcinoma (PDAC). Here, we investigated the effect of perineural invasion on the microenvironment and how this affects PDAC progression. Transcriptome expression profiles of PDAC tissues with different perineural invasion status were compared, and the intratumoral T-cell density and levels of neurotransmitters in these tissues were assessed. Perineural invasion was associated with impaired immune responses characterized by decreased CD8+ T and Th1 cells, and increased Th2 cells. Acetylcholine levels were elevated in severe perineural invasion. Acetylcholine impaired the ability of PDAC cells to recruit CD8+ T cells via HDAC1-mediated suppression of CCL5. Moreover, acetylcholine directly inhibited IFNγ production by CD8+ T cells in a dose-dependent manner and favored Th2 over Th1 differentiation. Furthermore, hyperactivation of cholinergic signaling enhanced tumor growth by suppressing the intratumoral T-cell response in an orthotopic PDAC model. Conversely, blocking perineural invasion with bilateral subdiaphragmatic vagotomy in tumor-bearing mice was associated with an increase in CD8+ T cells, an elevated Th1/Th2 ratio, and improved survival. In conclusion, perineural invasion–triggered cholinergic signaling favors tumor growth by promoting an immune-suppressive microenvironment characterized by impaired CD8+ T-cell infiltration and a reduced Th1/Th2 ratio. Significance: These findings provide a promising therapeutic strategy to modulate the immunosuppressive microenvironment of pancreatic ductal adenocarcinoma with severe perineural invasion.